Bevacizumab Monotherapy Improves DFI in Melanoma Patients at High Risk of Recurrence

Article Information

DOI 
http://dx.doi.org/10.1177/155989771306010
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Maria Vinall
  1. Pippa Corrie, PhD
    1. University of Cambridge, Cambridge, United Kingdom
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015100
Jul 2015100
Aug 2015100
Sep 2015100
Oct 2015143
Nov 2015100
Total1243

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Bevacizumab Monotherapy Improves DFI in Melanoma Patients at High Risk of Recurrence
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Oncology Clinical Trials
Soft Tissue Cancers
Oncology Clinical Trials
Soft Tissue Cancers
Oncology